Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed) — Opportunihub
Opportunihub Logo
Browse by industry — an index View all →
01 Information Technology 4 02 Banking & Insurance 3 03 Hospitality & Travel 2 04 Logistics & Transport 2 05 Marketing & Communications 2 06 Agriculture 2 07 Telecommunications 1 08 Education 1
By experience — stage
I Graduate Just starting out II Entry-level 0–2 years III Mid-level 2–5 years IV Senior 5–10 years V Executive 10+ years
Get hired faster
Create a profile
in two minutes.

Upload your CV once. Apply with one click. Track every conversation in one calm dashboard.

Sign up free
Home Jobs Companies Donors Career tools For employers About
Log in Get started
Grant ⏱ Apply by 28 Oct 2027

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

National Institutes of Health · United States

Apply on official site

At a glance

Type
Grant
Organisation
National Institutes of Health
Location
United States
Work mode
On-site
Deadline
28 Oct 2027
Posted
30 Sep 2026

About this grant

Funding agency: National Institutes of Health. Open: Sep 30, 2026 — Deadline: Oct 28, 2027. Opportunity #: RFA-MH-27-125. CFDA Program(s): 93.853, 93.242, 93.279. Visit Grants.gov to read the full Synopsis and apply.

How to apply

  1. 1 Read the full details above and confirm you meet the eligibility criteria.
  2. 2 Prepare your documents — an updated CV, and any cover letter, proposal or certificates required.
  3. 3 Click Apply on official site to complete your application on National Institutes of Health’s official page.
  4. 4 Submit before 28 Oct 2027.
Apply on official site

Sourced from grants_gov. Always verify details on the official website. Opportunihub never charges you to apply.

Frequently asked questions

How do I apply for Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)?

Review the full details and eligibility on this page, prepare your documents, then use the “Apply on official site” button to complete your application on National Institutes of Health’s official page before the 28 Oct 2027 deadline.

What is the application deadline?

Applications for this Grant close on Thursday, 28 October 2027 — about 369 day(s) from today.

Is this opportunity remote or location-based?

This opportunity is based in United States. Check the official listing for any relocation or on-site requirements.

Is Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed) free to apply for?

Opportunihub lists this Grant for free. Legitimate Grants do not ask for payment to apply — never pay a fee to submit an application.